Petlife Pharmaceuticals Inc
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concen… Read more
Petlife Pharmaceuticals Inc (PTLF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of February 2018: 0.082x
Based on the latest financial reports, Petlife Pharmaceuticals Inc (PTLF) has a cash flow conversion efficiency ratio of 0.082x as of February 2018.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-162.45K) by net assets ($-1.97 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Petlife Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2006–2017)
This chart illustrates how Petlife Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Petlife Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Petlife Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FBNVF
OTCGREY:FBNVF
|
N/A |
|
ZHEJIANG SHIBAO H YC 1
F:W4K1
|
N/A |
|
Quratis Inc.
KO:348080
|
N/A |
|
China Asset Management Co. Ltd. - Yuexiu Highway REIT Fund
SHE:180202
|
N/A |
|
Systematix Corporate Services Limited
NSE:SYSTMTXC
|
N/A |
|
Play2Chill SA
WAR:P2C
|
N/A |
|
ATVRockN
PINK:ATVK
|
0.046x |
|
Paint & Chemicals Industries (Pachin)
EGX:PACH
|
N/A |
Annual Cash Flow Conversion Efficiency for Petlife Pharmaceuticals Inc (2006–2017)
The table below shows the annual cash flow conversion efficiency of Petlife Pharmaceuticals Inc from 2006 to 2017.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2017-08-31 | $-1.38 Million | $-318.92K | 0.231x | +391.83% |
| 2016-08-31 | $-3.23 Million | $-151.84K | 0.047x | -22.22% |
| 2015-08-31 | $-365.13K | $-22.03K | 0.060x | -91.96% |
| 2012-08-31 | $-533.33K | $-400.12K | 0.750x | +276.71% |
| 2011-08-31 | $332.24K | $-141.05K | -0.425x | -848.87% |
| 2010-08-31 | $-562.08K | $-31.86K | 0.057x | -91.47% |
| 2009-08-31 | $-450.75K | $-299.59K | 0.665x | +40.83% |
| 2008-08-31 | $-535.88K | $-252.91K | 0.472x | -56.67% |
| 2007-08-31 | $-251.62K | $-274.03K | 1.089x | -95.19% |
| 2006-08-31 | $-2.12K | $-47.91K | 22.631x | -- |